Keeping Pace with Pharmaceutical Innovation: The Importance of the NICE Methods Review Paul CatchpoleVictoria Barrett Commentary Open access 24 April 2020 Pages: 901 - 903
Financing Drug Innovation in the US: Current Framework and Emerging Challenges David CutlerNoam KirsonGenia Long Current Opinion 26 May 2020 Pages: 905 - 911
Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence? Luiza Raquel GrazziotinGillian CurrieDeborah A. Marshall Systematic Review 11 May 2020 Pages: 913 - 926
Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review T. Joseph Mattingly IIBryan L. LoveBilal Khokhar Systematic Review Open access 12 June 2020 Pages: 927 - 939
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States Sang Kyu ChoBeenish S. ManzoorScott Johnson Original Research Article Open access 08 May 2020 Pages: 941 - 951
Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM Michael WillisAdam FridhammarPierre Johansen Original Research Article Open access 13 May 2020 Pages: 953 - 969
Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis Jesse ElliottBláthnaid McCoyDoug Coyle Original Research Article 14 May 2020 Pages: 971 - 980
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Thomas O’ConnellMarric BuessingIoannis Tomazos Original Research Article Open access 10 June 2020 Pages: 981 - 994
Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates Allison PortnoyKelsey VaughanNicolas A. Menzies Original Research Article Open access 28 June 2020 Pages: 995 - 1005
Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis Ning KamKanila PereraZanfina Ademi Original Research Article 13 August 2020 Pages: 1007 - 1020